Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Interim RECORD data support Avandia safety; FDA requests more prominent product labeling

June 8, 2007

THCV begins phase I for obesity and metabolic disorders

June 8, 2007

Favorable endometrial profile seen with bazedoxifene in postmenopausal women

June 8, 2007

Japanese launch for Somavert in acromegalia

June 7, 2007

Norditropin approved for short stature in children with Noonan syndrome

June 7, 2007

GlaxoSmithKline advances calcilytics program in osteoporosis

June 7, 2007

GSK's novel androgen receptor modulator improves muscle strength in orchidectomized animals

June 7, 2007

Metabasis presents preclinical results on its liver-targeted thyroid receptor agonist MB-07811

June 7, 2007

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

June 7, 2007

Divigel approved to treat menopausal hot flashes

June 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...